Although MOA, which had a far lower score, was considered because it formed a strong connection with both AChE and BChE and has a great deal of potential as a viable AD treatment target, AChE and BChE were chosen because they possessed significantly higher values in the PPI network. The gene discussed is BCHE; the disease is Alzheimer disease.